Relmada Therapeutics (RLMD) EPS (Basic) (2012 - 2026)
Relmada Therapeutics' (RLMD) quarterly EPS (Basic) came in at -$0.65 in Q1 2026, down 11.16% year-on-year from -$0.73 in Q1 2025, and down 28.81% on a QoQ basis from -$0.51 in Q4 2025.
Relmada Therapeutics (RLMD) EPS (Basic) (2012 - 2026) Analysis & Trends
Relmada Therapeutics (RLMD) has 15 years of EPS (Basic) data on file, last reported at -$0.65 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 11.16% year-over-year to -$0.65 in Q1 2026; TTM through Mar 2026 was -$1.11, a 56.18% increase from a year earlier, with the FY2025 full-year figure at -$1.64, up 38.67% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.65, down from -$0.51 in the prior quarter.
- Over the last five years, EPS (Basic) for RLMD reached as high as -$0.3 in Q2 2025 and fell as low as -$2.85 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.93 across 5 years, with a median of -$0.75 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 82.22% in 2022 and fell as far as 110.43% in 2022.
- Year by year, EPS (Basic) stood at -$1.32 in 2022, then surged by 35.6% to -$0.85 in 2023, then advanced by 28.07% to -$0.61 in 2024, then advanced by 17.29% to -$0.51 in 2025, then decreased by 28.81% to -$0.65 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.65 in Q1 2026, -$0.51 in Q4 2025, and -$0.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - | -0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.65 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.59 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.75 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -1.23 |
| Dec 31, 2023 | -0.85 |
| Sep 30, 2023 | -0.71 |
| Jun 30, 2023 | -0.82 |
| Mar 31, 2023 | -0.90 |
| Dec 31, 2022 | -1.32 |
| Sep 30, 2022 | -1.29 |
| Jun 30, 2022 | -1.52 |
| Mar 31, 2022 | -2.85 |
| Dec 31, 2021 | -7.43 |
| Sep 30, 2021 | -2.44 |
| Jun 30, 2021 | -1.55 |